Cargando…

Wnt signaling is involved in 6-benzylthioinosine-induced AML cell differentiation

BACKGROUND: We previously demonstrated that 6-benzylthioinosine (6-BT) could induce the differentiation of a subset of acute myeloid leukemia (AML) cell lines and primary AML cells regardless of their cytogenetics. In this study we investigated whether Wnt signaling pathways played roles in 6-BT-ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zang, Shaolei, Liu, Na, Wang, Hongchun, Wald, David N, Shao, Na, Zhang, Jingru, Ma, Daoxin, Ji, Chunyan, Tse, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289047/ https://www.ncbi.nlm.nih.gov/pubmed/25428027 http://dx.doi.org/10.1186/1471-2407-14-886

Ejemplares similares

Novel Agent Nitidine Chloride Induces Erythroid Differentiation and Apoptosis in CML Cells through c-Myc-miRNAs Axis
por: Liu, Na, et al.
Publicado: (2015)

Tumor Suppressor DYRK1A Effects on Proliferation and Chemoresistance of AML Cells by Downregulating c-Myc
por: Liu, Qiang, et al.
Publicado: (2014)

FZD7 regulates BMSCs-mediated protection of CML cells
por: Liu, Na, et al.
Publicado: (2015)

Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia
por: Li, Wei, et al.
Publicado: (2018)

Securinine, a Myeloid Differentiation Agent with Therapeutic Potential for AML
por: Gupta, Kalpana, et al.
Publicado: (2011)

TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1
por: Pang, Yihua, et al.
Publicado: (2020)

The emerging roles of Notch signaling in leukemia and stem cells
por: Liu, Na, et al.
Publicado: (2013)

PRKD2 Promotes Progression and Chemoresistance of AML via Regulating Notch1 Pathway
por: Liu, Qian, et al.
Publicado: (2019)

Subclones of bone marrow CD34(+) cells in acute myeloid leukemia at diagnosis confer responses of patients to induction chemotherapy
por: Jia, Ruinan, et al.
Publicado: (2022)

DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10–FGFR2 signaling
por: Yu, Shuang, et al.
Publicado: (2022)

Silencing of IRF8 Mediated by m6A Modification Promotes the Progression of T‐Cell Acute Lymphoblastic Leukemia
por: Zhou, Ying, et al.
Publicado: (2022)

METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4
por: Li, Mingying, et al.
Publicado: (2022)

The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia
por: Wang, Jingyi, et al.
Publicado: (2016)

Restoration of miR-23a expression by chidamide sensitizes CML cells to imatinib treatment with concomitant downregulation of CRYAB
por: Zhu, Xunxun, et al.
Publicado: (2022)

Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS/p38 MAPK/DGAT1 pathway and inhibiting M2 macrophage polarization
por: Liu, Jinting, et al.
Publicado: (2022)

Deacetylation of YAP1 Promotes the Resistance to Chemo- and Targeted Therapy in FLT3-ITD(+) AML Cells
por: Feng, Panpan, et al.
Publicado: (2022)

STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML
por: Oancea, Claudia, et al.
Publicado: (2014)

EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway
por: Yang, Xinyu, et al.
Publicado: (2023)

The role of Wnt signaling pathway in atherosclerosis and its relationship with angiogenesis
por: Du, Jingru, et al.
Publicado: (2018)

Corrigendum to “Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS/p38 MAPK/DGAT1 pathway and inhibiting M2 macrophage polarization” [Redox Biol. 56 (2022) 102452]
por: Liu, Jinting, et al.
Publicado: (2022)

Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma
por: Wang, Min, et al.
Publicado: (2015)

Wnt/β-Catenin Signaling and Obesity
por: Chen, Na, et al.
Publicado: (2018)

Cytoplasmic NEAT1 Suppresses AML Stem Cell Self‐Renewal and Leukemogenesis through Inactivation of Wnt Signaling
por: Yan, Huiwen, et al.
Publicado: (2021)

CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation
por: Federzoni, Elena A., et al.
Publicado: (2014)

CNS Involvement in AML Patient Treated with 5-Azacytidine
por: Vasilatou, Diamantina, et al.
Publicado: (2014)

Wnt co-receptors Lrp5 and Lrp6 differentially mediate Wnt3a signaling in osteoblasts
por: Sebastian, Aimy, et al.
Publicado: (2017)

miR-148b Regulates Proliferation and Differentiation of Neural Stem Cells via Wnt/β-Catenin Signaling in Rat Ischemic Stroke Model
por: Wang, Jingru, et al.
Publicado: (2017)

Differential diagnosis between AML infiltration, lymphoma and tuberculosis in a patient presenting with fever and mediastinal lymphadenopathy: A case report
por: ZHAO, NA, et al.
Publicado: (2014)

Differential involvement of Wnt signaling in Bmp regulation of cancellous versus periosteal bone growth
por: He, Guangxu, et al.
Publicado: (2017)

Progress of Wnt Signaling Pathway in Osteoporosis
por: Gao, Yongguang, et al.
Publicado: (2023)

Gene expression profiling of the DNMT3A R882 mutation in acute leukemia
por: HUANG, XIANGNAN, et al.
Publicado: (2013)

Gsdma3 regulates hair follicle differentiation via Wnt5a-mediated non-canonical Wnt signaling pathway
por: He, Long, et al.
Publicado: (2017)

The Alteration and Clinical Significance of Th22/Th17/Th1 Cells in Patients with Chronic Myeloid Leukemia
por: Chen, Ping, et al.
Publicado: (2015)

Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML
por: Islam, Mirazul, et al.
Publicado: (2017)

The Metabolic Signature of AML Cells Treated With Homoharringtonine
por: Zhang, Yulong, et al.
Publicado: (2022)

Analysis of the differential expression and prognostic relationship of DEGs in AML based on TCGA database
por: Gao, Yue, et al.
Publicado: (2023)

SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML
por: Ma, Shuang, et al.
Publicado: (2015)

Canonical Wnt signaling is involved in switching from cell proliferation to myogenic differentiation of mouse myoblast cells
por: Tanaka, Shingo, et al.
Publicado: (2011)

CDK6 Inhibition: A Novel Approach in AML Management
por: Uras, Iris Z., et al.
Publicado: (2020)

Repression of GSK3 restores NK cell cytotoxicity in AML patients
por: Parameswaran, Reshmi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1n2bdm5euh1kq6ble0ksvfdm53